PAVmed Q2 10-Q: Going Concern Warning, Covenant Amendment, and ATM Exhaustion
PAVM sits 18% above its 52-week low of $3.85 on elevated volume (4.5× avg).
Summary
PAVmed's Q2 2026 10-Q reveals a going concern warning, a covenant amendment requiring $5M deposit by Aug 25, and full utilization of its ATM facility, highlighting acute cash constraints.
Key Events · Earnings and Guidance · PAVM
-
Going Concern Warning Reiterated
Management states substantial doubt about the company's ability to continue as a going concern within one year, citing recurring losses and negative operating cash flows.
-
Minimum Cash Covenant Amended
Effective June 30, 2026, the covenant requires $2.5M in available cash (rising to $8.0M after Sept 15, 2026), contingent on depositing $5M in a blocked account by Aug 25, 2026.
-
ATM Facility Fully Utilized
Subsequent to quarter end, the company sold 675,679 shares for net proceeds of ~$2.8M, exhausting the $2.88M ATM capacity with no shares remaining.
-
Series D Conversion and Debt Refinancing
Series D Preferred Stock converted into 4,615,393 common shares on March 27, 2026; 2026 Note issued with $15.0M principal, 15% interest, and $450 conversion price.
Analysis · PAVM · Industrial Applications And Services
PAVmed's Q2 2026 report reiterates substantial doubt about its ability to continue as a going concern, with only $3.8M in cash and a net loss of $12.5M for the first half. The company amended its Minimum Cash Covenant to require $2.5M in available cash (rising to $8.0M after September 15, 2026), contingent on depositing $5M in a blocked account by August 25, 2026. The ATM facility has been fully utilized, raising $2.8M but leaving no further capacity. These factors indicate severe liquidity pressure and potential covenant breach risk.
How filings like this one have moved
In the 30 days to Oct 30, 2026, 38.3% of the 891 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.41%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, PAVM was trading at $4.55 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $33.9M. The 52-week trading range was $3.85 to $28.44. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.